BMS-1233
BMS-1233 is an orally active inhibitor for programmed cell death-ligand 1 (PD-L1), with IC50 of 14.5 nM. BMS-1233 promotes cell death of HepG2 in a Jurkat T cell and HepG2 cell co-culture model, exhibits antitumor activity against melanoma in mouse model[1].
Product Specifications
CAS Number
2447065-99-6
UNSPSC
12352005
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bms-1233.html
Smiles
N#CC1=CC=CC(COC2=CC(OCC3=CC=CC(C4=CC=CC=C4)=C3C)=C(C=C2CN5CCCCC5C(O)=O)Cl)=C1
Molecular Formula
C35H33ClN2O4
Molecular Weight
581.10
References & Citations
[1]Cheng B, et al., Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment. Signal Transduct Target Ther. 2023 Mar 1;8 (1) :91.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![hHR23A Recombinant Rabbit Monoclonal Antibody [JE38-49]](https://cdn.genprice.uk/products/992/68dd1c90061270361ea82aed/imageurl/ha722215.webp)
HA722215 100 µL
hHR23A Recombinant Rabbit Monoclonal Antibody [JE38-49]
Sign In for Pricing
View Details 
